Skip to main content

Table 1 Patient characteristics of HCs, GCA patients, PMR patients and disease control groups in both cohorts

From: Angiopoietin-2/-1 ratios and MMP-3 levels as an early warning sign for the presence of giant cell arteritis in patients with polymyalgia rheumatica

 

Aarhus cohort

Groningen GPS cohort

HC

GCA

Isolated PMR

GCA look-alike

HC

GCA

Isolated PMR

Infection control

n

 

19

52

25

18

45

48

39

16

Age

Years

66

67

68

70

71

72

73

73

Sex

% female

68

62

52

39

62

69

59

35

Classification criteria

 ACR for GCA

% pos

0

85

8

44

0

71

15

NA

 Chuang for PMR

% pos

0

19

68

0

0

15

72

NA

 ACR/EULAR for PMR

% pos

0

8

68

11

0

8

85

NA

Diagnostic tools

 TAB GCA

pos/neg/NA

NA

36/12/4

0/23/2

0/11/7

NA

23/7/18

0/7/32

NA

 PET GCA

pos/neg/NA

NA

48/4/0

0/25/0

0/13/5

NA

32/5/11

0/29/10

NA

 US GCA

pos/neg/NA

NA

47/5/0

2/23/0

1/23/1

NA

25/17/6

1/9/39

NA

Symptoms

 New headache

%

NA

60

12

50

NA

75

23

NA

 Jaw/tongue claudication

%

NA

21

0

6

NA

42

13

NA

 Abnormal temporal artery

%

NA

27

0

22

NA

50

8

NA

 Visual symptoms

%

NA

4

0

22

NA

29

0

NA

 Scalp tenderness

%

NA

33

8

28

NA

46

10

NA

 Limb claudication

%

NA

19

8

0

NA

19

15

NA

 Fever

%

NA

58

32

33

NA

33

15

NA

 Weight loss

%

NA

85

44

33

NA

63

49

NA

 Night sweats

%

NA

68a

36

33

NA

48

38

NA

 Malaise

%

NA

92

92

39

NA

75

85

NA

 Overlapping PMR

%

NA

25

NA

NA

NA

23

NA

NA

 Symptom duration, median

days

NA

88

56

NA

NA

47

114

NA

  1. aIn the Aarhus cohort, the presence or lack of night sweats was not recorded in 8 GCA patients